For
the year ended December 31, 2024 and 2023, respectively, the following common stock equivalents were excluded from the computation of
diluted net loss per share as the result of the computation was anti-dilutive.
SCHEDULE
OF ANTI-DILUTIVE BASIC AND DILUTED EARNINGS PER SHARE
| | |
2024 | | |
2023 | |
| | |
Years Ended December 31, | |
| | |
2024 | | |
2023 | |
| | |
(Shares) | | |
(Shares) | |
| Series A Preferred Stock | |
| 149,492,000 | | |
| 149,892,000 | |
| Stock options | |
| 864,887 | | |
| 9,765 | |
| Warrants | |
| 616,933 | | |
| 616,933 | |
| Total | |
| 150,973,820 | | |
| 150,518,698 | |
|